…
Healwell AI Inc. operates as a healthcare technology company in Canada, Australia, and New Zealand. The company operates in two segments, AI and Data Sciences, and Healthcare Software. It focuses on developing and commercializing clinical decision support systems to help healthcare providers detect rare and chronic diseases. The company provides healthcare artificial intelligence engines, electronic health record platform, healthcare data management and interoperability software, and early/late phase contract clinical research services. It also offers rare and chronic disease screening, real world evidence clinical study generation, advanced clinical decision support, and physical ASI co-pilot tools. It serves public sector organizations, healthcare providers, insurers, and life science companies. The company was formerly known as MCI Onehealth Technologies Inc. and changed its name to Healwell AI Inc. in September 2023. Healwell AI Inc. was incorporated in 2012 and is headquartered in Toronto, Canada.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Public information on HealWELL AI Inc. (AIDX.TO) is limited and lacks detailed operating descriptions or audited financials. Available materials indicate plans to develop healthcare artificial-intelligence solutions that could benefit from digitization of records and rising clinical AI adoption. Investors may find early-stage exposure to healthcare AI themes attractive but should weigh sparse disclosure and execution risk.
Principal risks are very limited disclosure and operating history, possible lack of revenue, regulatory and clinical validation challenges, execution risk, and low trading liquidity.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -39.78M | -28.28M | -32.68M | -17.08M | -16.29M |
| Minority interest | 0.55M | 1.19M | - | - | - |
| Net income | -46.94M | -26.29M | -32.19M | -21.09M | -15.67M |
| Selling general administrative | 53.49M | 42.69M | 9.06M | 11.36M | 30.18M |
| Selling and marketing expenses | - | 2.38M | 1.28M | 1.52M | 1.11M |
| Gross profit | 40.39M | 17.32M | 1.26M | 3.71M | 15.01M |
| Reconciled depreciation | 16.91M | 7.30M | - | - | - |
| Ebit | -29.53M | -25.71M | -17.59M | -17.55M | -16.43M |
| Ebitda | -12.62M | -18.42M | -16.11M | -15.01M | -12.12M |
| Depreciation and amortization | 16.91M | 7.30M | 1.48M | 2.54M | 4.31M |
| Operating income | -29.53M | -33.55M | -17.59M | -17.55M | -16.43M |
| Other operating expenses | 133.33M | 72.53M | 38.66M | 27.74M | 64.26M |
| Interest expense | 10.16M | 2.61M | - | 0.62M | 0.46M |
| Tax provision | -0.66M | -0.86M | - | 1.22M | -0.75M |
| Interest income | - | 0.64M | - | 1.03M | 0.35M |
| Net interest income | -9.59M | -1.97M | - | - | - |
| Extraordinary items | - | -0.05M | - | - | - |
| Income tax expense | -0.66M | -0.86M | 0.54M | 1.12M | -0.75M |
| Total revenue | 103.80M | 38.97M | 7.32M | 10.42M | 47.82M |
| Total operating expenses | 69.91M | 50.87M | 32.60M | 21.03M | 31.45M |
| Cost of revenue | 63.42M | 21.66M | 6.06M | 6.71M | 32.81M |
| Total other income expense net | -10.25M | 5.27M | -15.09M | 0.88M | 0.64M |
| Net income from continuing ops | -39.12M | -27.43M | - | - | - |
| Net income applicable to common shares | - | -26.29M | - | -21.09M | -15.67M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 284.99M | 125.53M | 53.70M | 45.63M | 60.89M |
| Intangible assets | 106.92M | 28.30M | 12.51M | 11.25M | 12.45M |
| Other current assets | 6.80M | 2.35M | 2.35M | 1.17M | 2.50M |
| Total liab | 161.04M | 51.86M | 32.23M | 33.85M | 32.86M |
| Total stockholder equity | 123.94M | 63.89M | 12.65M | 11.78M | 28.03M |
| Other current liab | 14.76M | 13.43M | 4.82M | - | - |
| Common stock | 250.43M | 140.08M | 67.37M | 39.79M | 39.79M |
| Capital stock | 250.43M | 140.08M | - | - | - |
| Retained earnings | -151.95M | -95.22M | -69.25M | -37.65M | -16.57M |
| Good will | 98.55M | 67.14M | 12.30M | 10.07M | 10.07M |
| Other assets | - | - | - | 0.47M | 1.95M |
| Cash | 18.63M | 9.41M | 19.16M | 1.41M | 7.14M |
| Total current liabilities | 70.77M | 23.32M | 9.42M | 19.39M | 14.49M |
| Current deferred revenue | 15.29M | 2.45M | - | - | - |
| Net debt | 67.49M | 12.79M | 0.76M | - | - |
| Short term debt | 26.38M | 2.73M | 0.67M | 7.00M | 0.00M |
| Short long term debt | 24.10M | 1.78M | - | - | - |
| Short long term debt total | 86.13M | 22.20M | 19.92M | - | - |
| Other stockholder equity | - | 19.02M | 12.57M | - | - |
| Property plant equipment | - | - | - | 10.44M | 13.93M |
| Total current assets | 64.67M | 18.33M | 22.76M | 8.61M | 16.51M |
| Long term investments | 8.31M | 4.48M | - | - | - |
| Short term investments | 0.00M | 0.27M | - | 0.39M | 0.54M |
| Net receivables | 39.23M | 6.29M | 1.24M | 4.29M | 3.22M |
| Long term debt | 56.37M | 14.24M | - | - | - |
| Accounts payable | 14.34M | 4.33M | 3.93M | - | - |
| Accumulated other comprehensive income | 25.46M | -0.00M | 1.96M | - | - |
| Non currrent assets other | 0.71M | 2.37M | 1.99M | - | - |
| Non current assets total | 220.31M | 107.21M | 30.94M | - | - |
| Capital lease obligations | 5.67M | 6.18M | - | - | - |
| Long term debt total | - | - | - | 9.33M | 11.26M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | 0.00M | -15.37M | - | - | - |
| Total cashflows from investing activities | -69.84M | -15.37M | - | -1.17M | -8.64M |
| Net borrowings | 71.27M | - | - | - | - |
| Total cash from financing activities | 95.50M | 28.24M | 27.20M | 3.78M | 21.99M |
| Net income | -38.56M | -27.48M | -31.60M | -20.97M | -15.54M |
| Change in cash | 9.22M | -9.75M | 17.75M | -5.73M | 6.25M |
| Begin period cash flow | 9.41M | 19.16M | 1.41M | 7.14M | 0.89M |
| End period cash flow | 18.63M | 9.41M | 19.16M | 1.41M | 7.14M |
| Total cash from operating activities | -19.42M | -22.62M | -10.80M | -8.35M | -7.10M |
| Issuance of capital stock | 23.59M | 19.12M | - | - | - |
| Depreciation | 16.91M | 7.30M | 2.80M | 2.54M | 4.31M |
| Other cashflows from investing activities | -0.92M | -1.22M | - | 0.00M | -6.28M |
| Dividends paid | 0.00M | - | - | 0.12M | 0.00M |
| Change to account receivables | 1.99M | 1.41M | 4.51M | 0.69M | -1.50M |
| Sale purchase of stock | - | -0.62M | - | 0.00M | -0.87M |
| Other cashflows from financing activities | -2.12M | 10.14M | 27.60M | -0.12M | -1.38M |
| Capital expenditures | 0.74M | 1.31M | 0.07M | 1.15M | 2.37M |
| Change in working capital | -17.18M | -2.83M | 4.56M | 2.21M | -1.65M |
| Stock based compensation | 12.99M | 7.14M | 3.26M | 4.83M | 6.11M |
| Other non cash items | 20.08M | -5.53M | 10.18M | -1.14M | -0.23M |
| Free cash flow | -20.16M | -23.93M | -10.86M | -9.49M | -9.47M |
Sector: Healthcare Industry: Medical Care Facilities
|
Stock Name
|
Change
(CAD) |
Price
(CAD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| AIDX HealWELL AI Inc. |
-0.01 1.52% |
0.65 | - | - | 2.81 | 2.35 | 3.46 | -4.93 |
| EXE Extendicare Inc |
-0.53 1.87% |
27.76 | 25.21 | 23.92 | 1.59 | 7.26 | 1.62 | 14.43 |
| SIA Sienna Senior Living Inc |
0.19 0.94% |
20.42 | 45.94 | 38.17 | 2.23 | 3.17 | 3.57 | 21.90 |
| WELL WELL Health Technologies Corp |
0.06 1.33% |
4.20 | - | 13.87 | 0.80 | 1.23 | 1.09 | 9.83 |
| DR Medical Facilities Corporation |
-0.01 0.07% |
15.03 | 15.57 | 12.94 | 1.18 | 2.87 | 0.92 | 3.64 |
Healwell AI Inc. operates as a healthcare technology company in Canada, Australia, and New Zealand. The company operates in two segments, AI and Data Sciences, and Healthcare Software. It focuses on developing and commercializing clinical decision support systems to help healthcare providers detect rare and chronic diseases. The company provides healthcare artificial intelligence engines, electronic health record platform, healthcare data management and interoperability software, and early/late phase contract clinical research services. It also offers rare and chronic disease screening, real world evidence clinical study generation, advanced clinical decision support, and physical ASI co-pilot tools. It serves public sector organizations, healthcare providers, insurers, and life science companies. The company was formerly known as MCI Onehealth Technologies Inc. and changed its name to Healwell AI Inc. in September 2023. Healwell AI Inc. was incorporated in 2012 and is headquartered in Toronto, Canada.
| Name | Title | Year Born |
|---|---|---|
| Mr. Donald Watts | President of Khure Health | NA |
| Dr. Alexander Julian Dobranowski | Founder, CEO, MD & Director | NA |
| Ms. Madeline D. Walker | President of MCI Medical | 1947 |
| Mr. Anthony Lam | Chief Financial Officer | NA |
| Paulo Gomes | Co-Chief Operating Officer | NA |
| Adam Hutton | Co-Chief Operating Officer | NA |
| Nolan Reeds | Vice President of Marketing & Communications | NA |
| Mr. Blake Corbet | Senior Vice President of Corporate Development | NA |
| Mr. Mark Findlay | Senior Vice President of Sales & Marketing for Canada | NA |
| Aaron Leibtag | Pentavere Research Group -CEO | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.